Back to drug safety directory
Combined estrogen-progestin contraceptionReviewed May 16, 2026

Oral Contraceptives (Birth Control Pills) and Ketamine Therapy | Tovani Health

Yaz (Oral Contraceptives) (also: Ortho Tri-Cyclen, Sprintec, Loestrin)Combined estrogen-progestin contraception

Verdict at Tovani Health

Fully compatible; no meaningful interaction.

Combined oral contraceptives and ketamine have no clinically significant interaction. KAP does not affect contraceptive efficacy, and OCPs do not affect ketamine response.

If you take Yaz regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Yaz interacts with ketamine

Combined OCPs suppress ovulation via estrogen and progestin. Hepatic metabolism is induced/inhibited by various agents but ketamine is not a relevant interactor.

What we do at intake

Continue as normal. If you take St. John's Wort, that DOES interact with OCPs (separate concern from ketamine).

Bottom line

Combined oral contraceptives and ketamine have no clinically significant interaction. KAP does not affect contraceptive efficacy, and OCPs do not affect ketamine response.

Frequently Asked Questions

Does ketamine affect birth control pill effectiveness?

No. Continue your regimen as prescribed.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Yaz (Oral Contraceptives) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Sources

The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.

  1. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI.. Clinical Pharmacokinetics. 2016. PMID: 27028535

    Comprehensive clinical pharmacokinetics/pharmacodynamics review of ketamine including CYP-mediated drug interactions (CYP3A4, CYP2B6).

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.